Suppr超能文献

肾移植12年后对低度肾细胞癌进行保留肾单位手术。

Nephron-sparing surgery of a low grade renal cell carcinoma in a renal allograft 12 years after transplantation.

作者信息

Mundel Thomas M, Schaefer Karl-Ludwig, Colombo-Benkmann Mario, Dietl Karl-Heinz, Diallo-Danebrock Raihana, Senninger Norbert

机构信息

Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Cancer Biol Ther. 2007 Nov;6(11):1700-3. doi: 10.4161/cbt.6.11.5165. Epub 2007 Oct 13.

Abstract

Renal cell carcinoma (RCC) occurring in renal allografts after cadaveric kidney transplantation has rarely been observed. RCC accounts for 2.3% of all malignancies in the general population, but up to 4.8% of malignancies in renal transplant recipients. Most have been reported in the patient's own diseased kidneys, whereas RCC in the renal allograft occur in only 10%. Here, we describe an organ-preserving surgical technique of a malignant renal tumor in a kidney allograft using a harmonic scalpel (Ultracision) for tumor enucleation. Furthermore we demonstrate by DNA microsatellite analysis the tumor's genetic origin as donor related. Collectively, we suggest that patients with a well defined low grade RCC in the kidney allograft and altogether low malignancy and good allograft function should only undergo an organ-preserving procedure and short-term postoperative screening.

摘要

尸体肾移植后肾移植受者发生肾细胞癌(RCC)的情况鲜有报道。RCC在普通人群的所有恶性肿瘤中占2.3%,但在肾移植受者的恶性肿瘤中占比高达4.8%。大多数病例报道的是患者自身患病的肾脏发生RCC,而肾移植肾中发生RCC的仅占10%。在此,我们描述了一种使用超声刀(超声切割止血刀)对肾移植肾中的恶性肾肿瘤进行肿瘤剜除的保器官手术技术。此外,我们通过DNA微卫星分析证明肿瘤的遗传起源与供体相关。我们共同建议,对于肾移植肾中明确诊断为低级别RCC、总体恶性程度低且移植肾功能良好的患者,仅应接受保器官手术及术后短期筛查。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验